2016_Head & Neck COURSE BOOK

Role of radiotherapy 

• Role of radiotherapy in salivary gland  carcinoma has never been assessed in  randomized trials R di th l i d l i • a o erapy a one can n uce ocoreg ona control rates of 40–50%, but high doses (66+  Gy) needed • Postoperative radiotherapy is indicated in  high risk patients – incomplete surgery – T3‐T4  – pN+ – perineural extension d id ti i d th hi h – a eno cys c carc noma an o er g  risk histologies l